Oct 132016
Talent4Boards - Great Talent builds Great Boards
– USA, CA – Inspyr Therapeutics, Inc. (OTC:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced today the appointment of Richard Buller, M.D., Ph.D.… => Read more
Inspyr Therapeutics appoints Dr Rich Buller to its Board of Directors
From:: Inspyr Therapeutics appoints Dr Rich Buller to its Board of Directors
Sorry, the comment form is closed at this time.